Covalon Technologies Ltd.

133 articles with Covalon Technologies Ltd.

• Covalon Announces Voting Results from Fiscal 2020 Annual and Special Meeting of Shareholders

  7/2/2021

  MISSISSAUGA, ON, July 2, 2021 /PRNewswire/ - Covalon Technologies Ltd., an advanced medical technologies company, announced the results of the matters voted upon at its Fiscal 2020 Annual and Special Meeting of Shareholders held June 30th, 2021.

• Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2021 Financial Results

  5/27/2021

  Covalon Technologies Ltd. (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, will release its Q2 Fiscal 2021 financial results on Monday, May 31 st , 2021 before markets open. A conference call to discuss the financial results will be held on Monday, May 31 st , 2021

• Covalon Announces Conference Call to Discuss First Quarter 2021 Financial Results

  2/26/2021

  MISSISSAUGA, ON, Feb. 26, 2021 /PRNewswire/ - Covalon Technologies Ltd., an advanced medical technologies company, will release its fiscal 2021 first quarter financial results on Monday March 1st 2021 before markets open.

• Covalon Announces Fiscal 2020 Year-End Results

  1/28/2021

  Covalon Technologies Ltd. an advanced medical technologies company, today announces its fiscal 2020 year-end results for the year ended September 30 , 2020. 

• Covalon Announces Appointment of Amir Boloor as Board Chair and Voting Results from Fiscal 2019 Annual and Special Meeting of Shareholders

  11/13/2020

  Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, today is pleased to announce the appointment of Amir Boloor , President of Caspian Equity Partners, Inc., as Chair of the Company's Board of Directors. Mr. Boloor, an independent directo

• Covalon Initiates Strategic Review to Enhance Shareholder Value

  10/21/2020

  Covalon Technologies Ltd. announced today that its Board of Directors has initiated a process to explore and evaluate a range of strategic alternatives available to the Company in order to enhance shareholder value.

• Covalon Announces Conference Call to Discuss Third Quarter Financial Results

  8/21/2020

  Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, will be releasing its Fiscal 2020 Third Quarter financial results on Monday August 24th, 2020, before markets open.

• Covalon Announces Second Quarter Fiscal 2020 Results

  7/14/2020

  Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announces its second quarter fiscal 2020 results. Brian Pedlar, Covalon’s President and CEO, said, “Like all businesses everywhere in the world, Covalon has been severely impacted by the COVID-19 pandemic. In response, the entire Covalon team has been working very hard to generate sa

• Covalon Provides Business Update

  6/30/2020

  Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, provides today an update on material business developments per Ontario Instrument 51-502 Temporary Exemption from Certain Corporate Financial Requirements . The Company continues to rely on th

• Covalon Granted Key Antimicrobial Patents in the United States, Canada, and Europe

  6/3/2020

  Covalon Technologies Ltd., an advanced medical technologies company, announced that the Company has been granted key antimicrobial patents by the United States Patent and Trademark Office, the Canadian Intellectual Property Office, and the European Patent Office.

• Amir Boloor Joins Covalon’s Board of Directors

  4/27/2020

  Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, is delighted to announce that Mr. Amir Boloor has joined its Board of Directors. Brian Pedlar, Covalon’s CEO, said, “I am delighted that Amir Boloor has agreed to join Covalon’s Board. Amir has been a significant long-time Covalon shareholder and he has much to offer us in terms of advice

• Martin Goldfarb, O.C., Joins Covalon’s Board of Directors

  4/23/2020

  Covalon Technologies Ltd., an advanced medical technologies company, is delighted to announce that Mr. Martin Goldfarb has joined its Board of Directors..

• Covalon Announces Conference Call to Discuss New CovaGuard Antimicrobial Technology

  4/3/2020

  Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announces a conference call to further discuss its new CovaGuard antimicrobial technology.

•  Covalon Announces New Breakthrough Antimicrobial Technology Formulated to Kill The COVID-19 Virus

  3/31/2020

  Covalon Announces New Breakthrough Antimicrobial Technology Formulated to Kill The COVID-19 Virus

• Covalon Clarifies Previous Press Release

  3/31/2020

  At the request of IIROC, Investment Industry Regulatory Organization of Canada, Covalon Technologies Ltd., an advanced medical technologies company, has been asked to clarify the press release issued earlier.

• Covalon Announces First Quarter Fiscal 2020 Results

  3/2/2020

  Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announces its first quarter fiscal 2020 results.

• Covalon Announces Conference Call to Discuss 2020 First Quarter Financial Results

  2/28/2020

  Covalon Technologies Ltd., an advanced medical technologies company, will be releasing its Fiscal 2020 First Quarter financial results on Monday, March 2nd, 2020, after markets close.

• Covalon Announces Fiscal 2019 Year-End Results and Plans for Fiscal 2020

  1/28/2020

  Covalon Technologies Ltd., an advanced medical technologies company, announces its fiscal 2019 year-end results and plans for fiscal 2020.

• Covalon Announces Conference Call to Discuss Year-End and Fourth Quarter 2019 Financial Results

  1/27/2020

  Covalon Technologies Ltd., an advanced medical technologies company, will release its Fiscal 2019 Fourth Quarter and Year-End financial results concurrently on Tuesday, January 28th, 2020 after markets close.

• Covalon Announces Closing of Non-Brokered Private Placement

  9/18/2019

  Covalon Technologies Ltd. announced that, further to its press release dated September 6, 2019, it has completed a non-brokered private placement offering comprised of approximately 2,750,000 units of the Corporation at a price of $2.00 per Unit for aggregate gross proceeds of approximately $5,500,000.